Gary H Lyman

Gary H Lyman

UNVERIFIED PROFILE

Are you Gary H Lyman?   Register this Author

Register author
Gary H Lyman

Gary H Lyman

Publications by authors named "Gary H Lyman"

Are you Gary H Lyman?   Register this Author

100Publications

2319Reads

38Profile Views

Cost effectiveness analysis of direct oral anticoagulant (DOAC) versus dalteparin for the treatment of cancer associated thrombosis (CAT) in the United States.

Thromb Res 2019 Aug 16;180:37-42. Epub 2019 May 16.

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2019.05.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661186PMC
August 2019

Direct Oral Anticoagulant for the Prevention of Thrombosis in Ambulatory Patients with Cancer: A Systematic Review and Meta-Analysis.

J Thromb Haemost 2019 Aug 17. Epub 2019 Aug 17.

Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jth.14613DOI Listing
August 2019

Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer.

Support Care Cancer 2019 Jun 7. Epub 2019 Jun 7.

Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-04875-1DOI Listing
June 2019

Addressing oncologists' gaps in the use of biosimilar products.

Am J Manag Care 2019 Jun;25(6 Spec No.):SP188-SP191

View Article

Download full-text PDF

Source
June 2019

New Biosimilar Approvals for Myeloid Growth Factors and Anemia.

Authors:
Gary H Lyman

J Natl Compr Canc Netw 2019 May;17(5.5):622-624

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2019.5016DOI Listing
May 2019

Multi-gene assays: effect on chemotherapy use, toxicity and cost in estrogen receptor-positive early stage breast cancer.

J Comp Eff Res 2019 Apr 21;8(5):289-304. Epub 2019 Jan 21.

Fred Hutchinson Cancer Center & The University of Washington, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer-2018-0137DOI Listing
April 2019

Biosimilars: what the oncologist should know.

Future Oncol 2019 Apr 22;15(10):1147-1165. Epub 2019 Feb 22.

Public Health Sciences and Research Divisions, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0728DOI Listing
April 2019

External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer.

Support Care Cancer 2019 Mar 8;27(3):921-925. Epub 2018 Aug 8.

University of Connecticut School of Medicine, Farmington, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4380-1DOI Listing
March 2019

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

N Engl J Med 2019 02;380(8):720-728

From the Department of Hematology and Medical Oncology, Taussig Cancer Institute and Case Comprehensive Cancer Center, Cleveland Clinic, Cleveland (A.A.K.); the Department of Medicine, Memorial Sloan Kettering Cancer Center (G.A.S., E.M.O.), and Weill Cornell Medical College (G.A.S., E.M.O.), New York; the Thrombosis Research Institute and University College London, London (A.K.K.); University of Texas M.D. Anderson Cancer Center, Houston (S.V.-R.), and U.S. Oncology Research-Texas Oncology, Tyler (H.A.Y.) - both in Texas; the Department of Medicine, Charité Universitätsmedizin Berlin, Berlin (H.R.); the Division of Hematology-Oncology, University of California Davis School of Medicine, Sacramento (T.W.), and the Keck School of Medicine, University of Southern California, Los Angeles (H.A.L.); the Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore (M.B.S.); the University of Washington School of Medicine (D.A.G., N.M.K., G.H.L.), Advanced Cancer Research Group (N.M.K.), and Fred Hutchinson Cancer Research Center (G.H.L.), Seattle; Penn State Cancer Institute, Milton S. Hershey Medical Center, Hershey, PA (C.P.B.); the Department of Cancer Pharmacology, Levine Cancer Institute, Atrium Health, Charlotte, NC (J.N.P.); Janssen Scientific Affairs, Titusville (P.W., P.B., S.K.), and Janssen Research and Development, Raritan (U.V.) - both in New Jersey; the Department of Medicine, McMaster University, Hamilton, ON, Canada (J.E.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (R.M.); and the Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston (K.A.B.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1814630
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1814630DOI Listing
February 2019

Febrile Neutropenia: An Ounce of Prevention or a Pound of Cure.

Authors:
Gary H Lyman

J Oncol Pract 2019 Jan;15(1):27-29

1 Fred Hutchinson Cancer Research Center; University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00750DOI Listing
January 2019

Lessons From Reporting National Performance Measures in a Regional Setting: Washington State Community Cancer Care Report.

J Oncol Pract 2018 12;14(12):e801-e814

Fred Hutchinson Cancer Research Center, Seattle, WA; Premera Blue Cross, Mountlake Terrace, WA; and University of Washington School of Medicine, Seattle, WA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00410
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00410DOI Listing
December 2018

Depression and Health Care Utilization at End of Life Among Older Adults With Advanced Non-Small-Cell Lung Cancer.

J Pain Symptom Manage 2018 11 17;56(5):699-708.e1. Epub 2018 Aug 17.

Hutchinson Institute for Cancer Outcomes Research Fred Hutchinson Cancer Research Center, Seattle, Washington, USA; Department of Pharmacy University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2018.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226016PMC
November 2018

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline.

J Clin Oncol 2018 Sep 11;36(25):2647-2655. Epub 2018 Jun 11.

Gary H. Lyman and Heather Greenlee, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Ting Bao and Gary E. Deng, Memorial Sloan Kettering Cancer Center; Dawn L. Hershman, Columbia University Medical Center, New York; Karen M. Mustian, University of Rochester Medical Center, Rochester, NY; Angela M. DeMichele, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Judith M. Fouladbakhsh, Oakland University, Rochester, MI; Brigitte Gil, Lahey Hospital and Medical Center, Burlington, MA; Sami Mansfield, Cancer Wellness for Life, Shawnee, KS; Sarah Cannon Cancer Institute, Kansas City, MO; Dawn M. Mussallem, The Mayo Clinic, Jacksonville, FL; Erin Price, Smith Center for Healing and the Arts, Washington, DC; Susan Rafte, Houston, TX; and Lorenzo Cohen, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.2721DOI Listing
September 2018

American Society of Clinical Oncology's Global Oncology Leadership Task Force: Findings and Actions.

J Glob Oncol 2018 Sep 11;4:1-8. Epub 2017 Aug 11.

Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Doug Pyle, American Society of Clinical Oncology, Alexandria, VA; Eduardo L. Cazap, Sociedad Latinoamericana y del Caribe de Oncología Médica, Buenos Aires, Argentina; Nagi S. El Saghir, American University of Beirut Medical Center, Beirut, Lebanon; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Boston, MA; Clement Adebayo Adebamowo, Institute of Human Virology, Baltimore, MD; David R. Gandara, University of California Davis Comprehensive Cancer Center, Sacramento, CA; Julie Vose, University of Nebraska Medical Center, Omaha, NE; Sandra L. Wong, Dartmouth-Hitchcock Medical Center, Lebanon, NH; and Peter Yu, Hartford HealthCare, Hartford, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.17.00060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180769PMC
September 2018

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update.

J Clin Oncol 2018 08 22;36(23):2433-2443. Epub 2018 May 22.

Neelima Denduluri, The US Oncology Network, Virginia Cancer Specialists; Jamie N. Holloway, Georgetown Breast Cancer Advocates, Arlington; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Mariana Chavez-MacGregor and Sharon H. Giordano, University of Texas MD Anderson Cancer Center, Houston, TX; Melinda L. Telli, Stanford University School of Medicine, Stanford; Arti Hurria, City of Hope, Duarte, CA; Andrea Eisen and Maureen E. Trudeau, Sunnybrook Odette Cancer Centre; Andrea Eisen and Maureen E. Trudeau, Cancer Care Ontario, Toronto, Ontario, Canada; Stephanie L. Graff, Sarah Cannon Cancer Institute HCA Midwest Health, Kansas City, MO; Michael J. Hassett, Tari A. King, and Ann H. Partridge, Dana-Farber Cancer Institute; Tari A. King, Brigham & Women's Cancer Center, Boston, MA; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; Antonio C. Wolff, Johns Hopkins Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.8604
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.8604DOI Listing
August 2018

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline Summary.

J Oncol Pract 2018 08;14(8):495-499

Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; American Society of Clinical Oncology, Alexandria, VA; The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00283DOI Listing
August 2018

Rationale, Opportunities, and Reality of Biosimilar Medications.

N Engl J Med 2018 08;379(7):694-695

Emory University, Atlanta, GA

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMc1808348
Publisher Site
http://dx.doi.org/10.1056/NEJMc1808348DOI Listing
August 2018

Immune-related Adverse Events in Cancer Patients.

Acad Emerg Med 2018 07 25;25(7):819-827. Epub 2018 May 25.

Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/acem.13443DOI Listing
July 2018

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).

J Clin Oncol 2018 07 10;36(20):2017-2023. Epub 2018 May 10.

Annie M. Young, Andrea Marshall, Jenny Thirlwall, Catherine Hill, Danielle Hale, Janet A. Dunn, and Stavros Petrou, Warwick Clinical Trials Unit, University of Warwick; Oliver Chapman and Christopher J. Poole, University Hospitals Coventry and Warwickshire; Charles Hutchinson and Jeremy Dale, Warwick Medical School, University of Warwick, Coventry; Anand Lokare, Heart of England National Health Service Foundation Trust, Birmingham; Peter MacCallum, Queen Mary University of London; Ajay Kakkar, Thrombosis Research Institute, London; F.D. Richard Hobbs, University of Oxford, Oxford; Anthony Maraveyas, Hull York Medical School, Hull, United Kingdom; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; and Mark Levine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.8034DOI Listing
July 2018

Reply to S.D. Lucio.

J Clin Oncol 2018 07 30;36(20):2127. Epub 2018 May 30.

Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle WA; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; R. Donald Harvey, Emory University, Atlanta GA; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.1780DOI Listing
July 2018

Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety.

J Clin Oncol 2018 06 9;36(18):1773-1776. Epub 2018 May 9.

Nicole M. Kuderer, Advanced Cancer Research Group, Seattle, WA; and Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.5592
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.5592DOI Listing
June 2018

Rationale, Opportunities, and Reality of Biosimilar Medications.

N Engl J Med 2018 May;378(21):2036-2044

From the Fred Hutchinson Cancer Research Center, Seattle (G.H.L.); Michiana Hematology Oncology, Mishawaka, IN (R.Z.); Emory University, Atlanta (R.D.H.); and the American Society of Clinical Oncology, Alexandria, VA (R.L.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMhle1800125DOI Listing
May 2018

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update Summary.

J Oncol Pract 2018 04 12;14(4):242-245. Epub 2017 Dec 12.

Dartmouth-Hitchcock Medical Center, Lebanon, NH; American Society for Clinical Oncology, Alexandria, VA; and Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.028241DOI Listing
April 2018

American Society of Clinical Oncology Statement: Biosimilars in Oncology.

J Clin Oncol 2018 04 14;36(12):1260-1265. Epub 2018 Feb 14.

Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.4893DOI Listing
April 2018

Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer.

Thromb Res 2018 04;164 Suppl 1:S112-S118

University of Washington, Seattle, WA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2018.01.028DOI Listing
April 2018

Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia.

Clin Lung Cancer 2018 03 28;19(2):e163-e169. Epub 2017 Oct 28.

Department of Medicine and Cancer Institute, Duke University Medical Center, Durham, NC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.10.013DOI Listing
March 2018

Oncology Clinical Pathways: Charting the Landscape of Pathway Providers.

J Oncol Pract 2018 03 7;14(3):e194-e200. Epub 2018 Feb 7.

Memorial Sloan Kettering Cancer Center, New York; Roswell Park Cancer Institute, Buffalo, NY; Michiana Hematology-Oncology, Mishawaka, IN; Center for Cancer and Blood Disorders, Fort Worth, TX; Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; American Society of Clinical Oncology, Alexandria, VA; and City of Hope, Rancho Cucamonga, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.17.00033DOI Listing
March 2018

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2018 02 12;36(4):399-413. Epub 2017 Dec 12.

Sandra L. Wong, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Mark B. Faries, The Angeles Clinic and Research Institute, Santa Monica; Alistair Cochran, University of California, Los Angeles Center for Health Services, Los Angeles, CA; Erin B. Kennedy, American Society of Clinical Oncology, Alexandria, VA; Sanjiv S. Agarwala, St Luke's Cancer Center, Easton; John M. Kirkwood, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Timothy J. Akhurst, Peter MacCallum Cancer Centre, Victoria, Australia; Charlotte Ariyan, Memorial Sloan Kettering Cancer Center, New York, NY; Charles M. Balch, MD Anderson Cancer Center, Houston, TX; Barry S. Berman, Broward Health, Fort Lauderdale; Jonathan S. Zager, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Keith A. Delman, Emory University, Atlanta, GA; Mark Gorman, Silver Spring, MD; Marc D. Moncrieff, Norfolk and Norwich University Hospital, Norwich, United Kingdom; and Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.7724DOI Listing
February 2018

Patient-reported outcomes in acute myeloid leukemia: Where are we now?

Blood Rev 2018 01 1;32(1):81-87. Epub 2017 Sep 1.

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2017.08.010DOI Listing
January 2018

A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.

Support Care Cancer 2018 01 22;26(1):7-20. Epub 2017 Sep 22.

Department of Medicine, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3854-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827957PMC
January 2018

Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.

BMC Cancer 2018 01 6;18(1):44. Epub 2018 Jan 6.

Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, 1100 Fairview Ave N, Seattle, Washington, 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3922-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756362PMC
January 2018

Chemotherapy Use at the End of Life in Uganda.

J Glob Oncol 2017 Dec 18;3(6):711-719. Epub 2017 Jan 18.

Daniel Low, Emily C. Merkel, Manoj Menon, Gary H. Lyman, and Corey Casper, University of Washington School of Medicine; Manoj Menon, Gary H. Lyman, Henry Ddungu, and Corey Casper, Fred Hutchinson Cancer Research Center, Seattle, WA; Henry Ddungu, Uganda Cancer Institute; and Elizabeth Namukwaya and Mhoira Leng, Makerere/Mulago Palliative Care Unit, Kampala, Uganda.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.2016.007385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735970PMC
December 2017

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2017 Oct 31;35(28):3240-3261. Epub 2017 Jul 31.

Paul J. Hesketh, Lahey Hospital and Medical Center, Burlington; Kimberly Noonan, Dana-Farber Cancer Institute, Boston, MA; Mark G. Kris, Memorial Sloan Kettering Cancer Center, New York, NY; Ethan Basch and Stacie B. Dusetzina, University of North Carolina at Chapel Hill, Chapel Hill; Sally Y. Barbour, Duke University Medical Center, Durham, NC; Kari Bohlke and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Virginia Beach; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Rebecca Anne Clark-Snow, University of Kansas Cancer Center, Westwood, KS; Cathy Eng, The University of Texas MD Anderson Cancer Center, Houston, TX; Dee Sparacio, Patient Representative, Hightstown, NJ; Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Kristopher Dennis, The Ottawa Hospital and University of Ottawa, Ottawa; L. Lee Dupuis, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Petra C. Feyer, Vivantes Clinics Neukoelln, Berlin; and Karin Jordan, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.4789DOI Listing
October 2017

Emerging Opportunities and Challenges of Biosimilars in Oncology Practice.

Authors:
Gary H Lyman

J Oncol Pract 2017 09;13(9_suppl):7s-9s

Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.026831DOI Listing
September 2017

Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort Study.

JNCI Cancer Spectr 2017 Sep 28;1(1):pkx009. Epub 2017 Nov 28.

Hematology/Oncology, Cleveland Clinic, Cleveland, OH (DPSS, MFK, KM, AAK); Hematology/Oncology, University of Washington, Seattle, WA (NMK, GHL); Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (FAS); Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria (IP); Stroke Unit, Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy (GA); Jane Anne Nohl Devision of Hematology, University of Southern California, Los Angeles, CA (HAL); Respiratory and Intensive Care Medicine, Universite Paris Descartes, Paris, France (GM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncics/pkx009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649852PMC
September 2017

Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.

JAMA Oncol 2017 07;3(7):996-998

Department of Medicine, University of Washington, Seattle2Center for Cancer Innovation, University of Washington, Seattle5Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.4983DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824236PMC
July 2017

Impact of the elimination of cost sharing for mammographic breast cancer screening among rural US women: A natural experiment.

Cancer 2017 Jul 14;123(13):2506-2515. Epub 2017 Feb 14.

University of North Carolina School of Global Public Health, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30629DOI Listing
July 2017

Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement.

J Clin Oncol 2017 Jun 30;35(16):1845-1854. Epub 2017 Mar 30.

Kala Visvanathan, Johns Hopkins Bloomberg School of Public Health and Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD; Laura A. Levit and Clifford A. Hudis, American Society of Clinical Oncology, Alexandria, VA; Derek Raghavan, Carolinas HealthCare System, Charlotte, NC; Sandra Wong, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Amylou Dueck, Mayo Clinic, Rochester, MN; and Gary H. Lyman, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6414DOI Listing
June 2017

Costs, Trends, and Related Factors in Treating Lung Cancer Patients in 67 Hospitals in Guangxi, China.

Cancer Invest 2017 May 3;35(5):345-357. Epub 2017 Apr 3.

c Division of Public Health Science , Fred Hutchinson Cancer Research Center and University of Washington , Seattle , Washington , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357907.2017.1296156DOI Listing
May 2017

Predicting neutropenia risk in patients with cancer using electronic data.

J Am Med Inform Assoc 2017 Apr;24(e1):e129-e135

Hutchinson Institute for Cancer Outcomes Research, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jamia/ocw131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277060PMC
April 2017

Reply to L. Del Mastro and A. Prat.

J Clin Oncol 2017 04 17;35(10):1139. Epub 2017 Jan 17.

Neelima Denduluri, Virginia Cancer Specialists, US Oncology Network, Arlington, VA; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Andrea Eisen, Sunnybrook Odette Cancer Centre, and Cancer Care Ontario, Toronto, Canada; Jamie N. Holloway, Arlington, VA; Arti Hurria, City of Hope, Duarte, CA; Tari A. King, Dana-Farber Cancer Institute, and Brigham & Women's Cancer Center; Boston, MA; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Melinda L. Telli, Stanford University, Palo Alto, CA; Maureen E. Trudeau, Sunnybrook Health Sciences Centre, and Cancer Care Ontario, Toronto, Canada; and Antonio C. Wolff, Johns Hopkins Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.70.9758
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.70.9758DOI Listing
April 2017

Association of Risk Factors, Mortality, and Care Costs of Adults With Acute Myeloid Leukemia With Admission to the Intensive Care Unit.

JAMA Oncol 2017 Mar;3(3):374-381

Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, Washington3Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington7Division of Medical Oncology, Department of Medicine, University of Washington, Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.4858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344736PMC
March 2017

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: 2016 American Society of Clinical Oncology Clinical Practice Guideline Update Summary.

J Oncol Pract 2017 03 24;13(3):196-198. Epub 2017 Jan 24.

Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; American Society of Clinical Oncology, Alexandria, VA; and Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.019992DOI Listing
March 2017

American Society of Clinical Oncology Criteria for High-Quality Clinical Pathways in Oncology.

J Oncol Pract 2017 03 7;13(3):207-210. Epub 2017 Feb 7.

Michiana Hematology-Oncology PC, Mishawaka, IN; Roswell Park Cancer Institute, Buffalo, NY; The Center for Cancer and Blood Disorders, Fort Worth, TX; Charleston Area Medical Center, Charleston, WV; Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Cancer Research Advocate, Grand Island, NE; American Society of Clinical Oncology, Alexandria, VA; and City of Hope, Rancho Cucamonga, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.019836DOI Listing
March 2017

Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor.

Support Care Cancer 2017 02 12;25(2):439-447. Epub 2016 Oct 12.

Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-016-3421-xDOI Listing
February 2017

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2017 Feb 12;35(5):561-564. Epub 2016 Dec 12.

Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Linda D. Bosserman, City of Hope, Duarte, CA; Cheryl L. Perkins, Dallas, TX; Donald L. Weaver, University of Vermont and Vermont Cancer Center, Burlington, VT; and Armando E. Giuliano, Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.0947DOI Listing
February 2017

Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models.

Expert Rev Pharmacoecon Outcomes Res 2017 Feb 20;17(1):39-52. Epub 2017 Jan 20.

f Department of Health Policy and Management; Department of Biostatistics , Harvard T.H. Chan School of Public Health , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737167.2017.1276829DOI Listing
February 2017

Risk of infection among patients with non-metastatic solid tumors or non-Hodgkin's lymphoma receiving myelosuppressive chemotherapy and antimicrobial prophylaxis in US clinical practice.

J Oncol Pharm Pract 2017 Jan 9;23(1):33-42. Epub 2016 Jul 9.

4 Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155215614997DOI Listing
January 2017

Issues on the Use of White Blood Cell Growth Factors in Oncology Practice.

Authors:
Gary H Lyman

Am Soc Clin Oncol Educ Book 2016 ;35:e528-32

From the Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, and the University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_156064DOI Listing
January 2017

Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma.

Expert Opin Drug Saf 2016 11;15(4):483-92. Epub 2016 Mar 11.

a Hutchinson Institute for Cancer Outcomes Research , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.2016.1146675DOI Listing
December 2016

Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors With Chemotherapy for Breast Cancer.

J Clin Oncol 2016 11 30;34(32):3872-3879. Epub 2016 Sep 30.

Abiy Agiro, Qinli Ma, Sze-jung Wu, and John J. Barron, HealthCore, Wilmington, DE; Anupama Kurup Acheson, Providence Cancer Center, Portland, OR; Debra A. Patt, Texas Oncology, Austin; Debra A. Patt, The US Oncology Network, Houston, TX; Jennifer L. Malin, Anthem, Woodland, CA; Alan Rosenberg, Anthem, Chicago, IL; Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research and University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.2899DOI Listing
November 2016

Innovations in American Society of Clinical Oncology Practice Guideline Development.

J Clin Oncol 2016 09 5;34(26):3213-20. Epub 2016 Jul 5.

Mark R. Somerfield, Kari Bohlke, Kaitlin Einhaus, Robert S. Miller, Thomas K. Oliver, and Eduardo Ortiz, American Society of Clinical Oncology, Alexandria; Neelima Denduluri, U.S. Oncology Network, Virginia Cancer Specialists, Arlington, VA; George P. Browman, McMaster University, Hamilton, Ontario; University of British Columbia, Vancouver, British Columbia, Canada; Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Alok A. Khorana, Cleveland Clinic, Cleveland, OH; Supriya G. Mohile, University of Rochester, Rochester, NY; and Gary H. Lyman, Fred Hutchinson Cancer Research Center; University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.3524DOI Listing
September 2016

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.

J Clin Oncol 2016 08 31;34(24):2925-34. Epub 2016 May 31.

Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Harvard Medical School; Therese Mulvey and Jeffrey Peppercorn, Massachusetts General Hospital; Deborah Schrag, Dana-Farber Cancer Institute, Boston, MA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh; Adam P. Dicker, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA; Dana S. Wollins and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Douglas W. Blayney, Stanford University Medical Center, Stanford; Patricia A. Ganz, Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles; Peter P. Yu, Palo Alto Medical Foundation, Palo Alto, CA; J. Russell Hoverman, Texas Oncology, Dallas, TX; Robert Langdon, Nebraska Cancer Specialists; Julie M. Vose, University of Nebraska Medical Center, Omaha, NE; Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Neal J. Meropol, University Hospitals Case Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center, and Case Western Reserve University, Cleveland, OH; Lee Newcomer, UnitedHealthcare, Minneapolis, MN; Blase Polite, University of Chicago Medicine, Chicago, IL; Derek Raghavan, Levine Cancer Institute, Charlotte, NC; Gregory Rossi, AstraZeneca, Macclesfield, United Kingdom; Leonard Saltz and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; and Thomas J. Smith, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2518DOI Listing
August 2016

Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline.

J Clin Oncol 2016 07 18;34(20):2416-27. Epub 2016 Apr 18.

Neelima Denduluri, US Oncology Network, Virginia Cancer Specialists, Arlington; Jamie N. Holloway, Patient Representative, Arlington; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Andrea Eisen and Maureen E. Trudeau, Sunnybrook Health Sciences Centre, and Cancer Care Ontario, Toronto, Ontario, Canada; Arti Hurria, City of Hope, Duarte; Melinda L. Telli, Stanford University, Palo Alto, CA; Tari A. King, Dana-Farber/Brigham and Women's Cancer Center; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; and Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.0182DOI Listing
July 2016

Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.

N Engl J Med 2016 Jul 1;375(1):4-6. Epub 2016 Jun 1.

From the Fred Hutchinson Cancer Research Center and the University of Washington - both in Seattle (G.H.L.); the Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies, National Academies of Sciences, Engineering, and Medicine, Washington, DC (G.H.L., H.L.M.); and Vanderbilt University, Nashville (H.L.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1604033DOI Listing
July 2016

Evaluation and Regulation of Oncology Drug Approval: Finding the Right Balance.

Authors:
Gary H Lyman

JAMA Oncol 2016 Jun;2(6):728-9

Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.6477DOI Listing
June 2016

Biomarker Tests for Molecularly Targeted Therapies: Laying the Foundation and Fulfilling the Dream.

J Clin Oncol 2016 06 11;34(17):2061-6. Epub 2016 Apr 11.

Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; and Harold L. Moses, Vanderbilt University, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.3160DOI Listing
June 2016

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.

CA Cancer J Clin 2016 Jan-Feb;66(1):43-73. Epub 2015 Dec 7.

Distinguished Professor of Medicine and Health Policy & Management, Schools of Medicine and Public Health, University of California, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21319DOI Listing
May 2016

American Cancer Society Head and Neck Cancer Survivorship Care Guideline.

CA Cancer J Clin 2016 05 22;66(3):203-39. Epub 2016 Mar 22.

Director, The George Washington University Cancer Institute, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21343DOI Listing
May 2016

Addressing Skyrocketing Cancer Drug Prices Comes With Tradeoffs: Pick Your Poison.

JAMA Oncol 2016 Apr;2(4):425-6

Patient Advocacy Committee, SWOG, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.5813DOI Listing
April 2016

Changing patterns of chemotherapy relative dose intensity and supportive care for aggressive B-cell non-Hodgkin lymphoma.

Leuk Lymphoma 2016 Feb 7;57(2):283-290. Epub 2015 Jul 7.

d University of Washington , Seattle , WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1045894DOI Listing
February 2016

Antiemetics: American Society of Clinical Oncology Focused Guideline Update.

J Clin Oncol 2016 Feb 2;34(4):381-6. Epub 2015 Nov 2.

Paul J. Hesketh, Lahey Hospital and Medical Center, Burlington, MA; Kari Bohlke and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Norfolk and Virginia Beach, VA; Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Maurice Chesney, patient representative, Saunderstown, RI; Rebecca Anne Clark-Snow, University of Kansas Cancer Center, Westwood, KS; Karin Jordan, University Hospital, Martin-Luther-University Halle-Wittenberg, Halle, Germany; and Mark G. Kris, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.64.3635
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.64.3635DOI Listing
February 2016

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.

J Clin Oncol 2016 Feb 7;34(6):611-35. Epub 2015 Dec 7.

Carolyn D. Runowicz, Herbert Wertheim College of Medicine, Florida International University; Karen S. Henry, Sylvester Cancer Center at the University of Miami, Miami, FL; Corinne R. Leach, Rebecca L. Cowens-Alvarado, Rachel S. Cannady, and Samuel J. LaMonte, American Cancer Society, Atlanta, GA; N. Lynn Henry, University of Michigan, Comprehensive Cancer Center, Ann Arbor, MI; Heather T. Mackey, Oncology Nursing Society, Pittsburgh; Linda A. Jacobs, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Mandi L. Pratt-Chapman, The George Washington University Cancer Institute, Washington, DC; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; Arti Hurria, City of Hope, Duarte; Patricia A. Ganz, Schools of Medicine and Public Health, University of California, Los Angeles, CA; Lawrence B. Marks, University of North Carolina, Chapel Hill, NC; Ellen Warner, University of Toronto, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; and Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA doi: 10.3322/caac.21319. Available online at cacancerjournal.com.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.3809DOI Listing
February 2016

Reply to M.G. McNamara et al and T.H. Oo.

J Clin Oncol 2016 Feb 4;34(5):517-8. Epub 2016 Jan 4.

University of Washington; and Seattle Cancer Care Alliance, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.1399DOI Listing
February 2016

Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.

Blood 2015 Dec 26;126(26):2790-7. Epub 2015 Oct 26.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Medicine, Division of Hematology, and Department of Epidemiology, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-07-627323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692139PMC
December 2015

Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.

JAMA Oncol 2015 Nov;1(8):1098-109

Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina3Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2015.2722DOI Listing
November 2015

Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices.

J Natl Compr Canc Netw 2015 Nov;13(11):1383-93

From Virginia Cancer Specialists PC and The US Oncology Network, Arlington, Virginia; McKesson Specialty Health and The US Oncology Network, The Woodlands, Texas; Amgen Inc., Thousand Oaks, California; Virginia Cancer Specialists PC and The US Oncology Network, Fairfax, Virginia; Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
November 2015

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2015 Oct 13;33(28):3199-212. Epub 2015 Jul 13.

Thomas J. Smith, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kari Bohlke, American Society of Clinical Oncology, Alexandria; Scott J. Cross, Virginia Oncology Associates, Norfolk; James L. Khatcheressian, Virginia Cancer Institute, Richmond, VA; Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Kenneth R. Carson, Washington University, St Louis, MO; Jeffrey Crawford, Duke Medicine, Durham, NC; John M. Goldberg, University of Miami Miller School of Medicine, Miami, FL; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Cheryl L. Perkins, patient representative, Dallas, TX; George Somlo, City of Hope National Medical Center, Duarte, CA; James L. Wade, Cancer Care Specialists of Central Illinois, Decatur, IL; Antoinette J. Wozniak, Karmanos Cancer Institute, Detroit, MI; and James O. Armitage, University of Nebraska Medical Center, Omaha, NE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.3488DOI Listing
October 2015

Resource Utilization for Chemotherapy-Induced Nausea and Vomiting Events in Patients with Solid Tumors Treated with Antiemetic Regimens.

Am Health Drug Benefits 2015 Jul-Aug;8(5):273-82

Co-Director, Hutchinson Institute for Cancer Outcomes Research, Public Health Sciences and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567059PMC
September 2015

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.

J Clin Oncol 2015 Aug 22;33(23):2563-77. Epub 2015 Jun 22.

Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Harvard Medical School; Jeffrey Peppercorn, Massachusetts General Hospital; Deborah Schrag, Dana-Farber Cancer Institute, Boston; Therese Mulvey, Southcoast Centers for Cancer Care, Fall River, MA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh; Adam P. Dicker, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA; Dana S. Wollins, Courtney Tyne, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Douglas W. Blayney, Stanford University Medical Center, Stanford; Patricia A. Ganz, Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles; Peter P. Yu, Palo Alto Medical Foundation, Palo Alto, CA; Diane Blum, National Executive Service Corps; Leonard Saltz and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; J. Russell Hoverman, Texas Oncology, Dallas, TX; Robert Langdon, Nebraska Cancer Specialists, Omaha, NE; Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Neal J. Meropol, University Hospitals Case Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH; Lee Newcomer, UnitedHealthcare, Minneapolis, MN; Blase Polite, University of Chicago Medicine, Chicago, IL; Derek Raghavan, Levine Cancer Institute, Charlotte, NC; Gregory Rossi, AstraZeneca, Macclesfield, Cheshire, United Kingdom; and Thomas J. Smith, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.61.6706
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.61.6706DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015427PMC
August 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort study.

Springerplus 2015 6;4:396. Epub 2015 Aug 6.

Fred Hutchinson Cancer Research Center, Hutchinson Institute for Cancer Outcomes Research, 1100 Fairview Avenue North, M3-B232, PO Box 19024, Seattle, WA 98109-1024 USA ; University of Washington, Seattle, WA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40064-015-1165-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524886PMC
August 2015

Importance of Risk Factors for Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified as High-Risk in Guidelines for Myeloid Growth Factor Use.

J Natl Compr Canc Netw 2015 Aug;13(8):979-86

From Policy Analysis Inc. (PAI), Brookline, Massachusetts; Amgen Inc., Thousand Oaks, California; Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, Texas Medical Center, University of Houston, Houston, Texas; and Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
August 2015

When to Offer Thromboprophylaxis to Patients With Advanced Pancreatic Cancer: Shedding Light on the Path Forward.

J Clin Oncol 2015 Jun 18;33(18):1995-7. Epub 2015 May 18.

University of Washington; and Seattle Cancer Care Alliance, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.4164DOI Listing
June 2015

Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.

JAMA Oncol 2015 May;1(2):158-66

Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina3Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.43DOI Listing
May 2015